MAYNE PHARMA GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.66 AUD | -1.33% |
|
-5.67% | +8.29% |
| Feb. 26 | Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15% | MT |
| Feb. 25 | Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024 |
Chart calendar Mayne Pharma Group Limited
1903.4zB3og-840r1psbPfJQT-_15jfUfq-EqoylUOT_hQ_c.kQgb62r5jC7Y4pSsLPpWuZEQ9LR30plHwFkQDw3SFYS2Yyb4OYWWDKHctQ~77bea3f8de663fe6fb311eedc75c8a10
Upcoming events on Mayne Pharma Group Limited
Past events on Mayne Pharma Group Limited
| 2024-02-25 05:00 pm | Q2 2024 Earnings Call |
| 2024-02-25 04:20 pm | Q2 2024 Earnings Release |
| 2024-01-11 10:30 am | JPMorgan Healthcare Conference |
| 2023-11-29 06:00 pm | Annual General Meeting |
| 2023-11-14 09:00 am | Jefferies London Healthcare Conference |
| 2023-10-17 07:00 pm | Q1 2024 Sales and Revenue Call - Trading Update |
| 2023-10-17 06:14 pm | Q1 2024 Sales and Revenue Release - Trading Update |
| 2023-09-11 09:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-30 07:30 pm | Q4 2023 Earnings Call |
| 2023-08-30 07:05 pm | Q4 2023 Earnings Release |
| 2023-06-09 11:00 am | Jefferies Global Healthcare Conference |
| 2023-05-15 12:30 pm | JMP Securities Life Sciences Conference |
| 2023-05-09 07:30 pm | Mayne Pharma Group Limited Divestment Call |
| 2023-02-27 05:00 pm | Q2 2023 Earnings Call |
| 2023-02-27 04:55 pm | Q2 2023 Earnings Release |
| 2023-01-17 | Reverse Split: 1 of 20 |
| 2023-01-17 | Ex-dividend day for extraordinary dividend |
| 2023-01-11 | JP Morgan Healthcare Conference |
| 2022-11-29 05:00 pm | Annual General Meeting |
| 2022-08-25 07:00 pm | FY 2022 Earnings Call |
Past dividends on Mayne Pharma Group Limited
| 2023-01-17 | Bonus Payment 0.0272 AUD |
Annual results
| Fiscal Period | June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 525 525 -0.04% | 457 455 0.42% | 401 416 -3.57% | 425 415 2.32% | 184 268 -31.46% | 384 |
|
EBITDA Million AUD | Released Forecast Spread | 131 135 -2.8% | 95,3 87,8 8.57% | 63,5 67,4 -5.75% | 45,7 50,2 -8.97% | -95,3 -76,2 -25.06% | 23,7 |
|
EBIT Million AUD | Released Forecast Spread | 37,2 43,3 -14.06% | 11,7 12,8 -8.92% | -3,70 -15,3 75.87% | -34,5 -34,9 1.14% | -161 -160 -0.42% | -46,7 |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -354 27,0 -1410.06% | -135 -37,5 -260.98% | -264 -258 -2.24% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
Net income Million AUD | Released Forecast Spread | -281 11,2 -2598.73% | -92,8 -33,3 -178.36% | -208 -173 -20.55% | -263 -72,1 -265.47% | 117 -176 166.55% | -83,7 |
|
EPS AUD | Released Forecast Spread | -3,81 0,17 -2331.21% | -1,21 -0,28 -327.46% | -2,65 -1,88 -40.78% | -3,20 -0,80 -301.86% | 1,48 -1,03 243.24% | -1,02 |
| Announcement Date | 22/08/19 | 20/08/20 | 26/08/21 | 25/08/22 | 30/08/23 | - |
Quarterly results
| Fiscal Period | June | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2025 S1 | 2025 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 227 237 -3.99% | 230 221 3.87% | 209 209 0.1% | 192 205 -6.54% | 196 205 -4.59% | 228 209 9.03% | 82,4 161 -48.78% | 188 | 201 | 203 | |
|
EBITDA Million AUD | Released Forecast Spread | 47,4 40,6 16.89% | 47,9 40,1 19.45% | 39,9 44,9 -11.07% | 23,6 23,0 2.61% | 23,7 23,4 1.5% | 22,0 28,6 -23.08% | -42,2 -25,5 -65.49% | ||||
|
EBIT Million AUD | Released Forecast Spread | -12,3 3,00 -510% | 24,0 4,80 400% | 2,30 2,75 -16.36% | -6,00 -16,9 64.39% | -17,6 -12,2 -44.86% | -16,9 -12,1 -39.67% | |||||
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -25,0 -4,35 -473.79% | -110 -13,5 -717.83% | -229 -12,3 -1771.47% | -34,6 -27,1 -27.79% | -63,7 -21,1 -201.91% | -154 -27,7 -456.38% | |||||
|
Net income Million AUD | Released Forecast Spread | -17,5 -3,25 -438.46% | -75,3 -14,0 -439.78% | -181 -8,70 -1983.75% | -27,1 -18,7 -44.99% | -50,4 -14,8 -240.54% | -213 -19,4 -997.8% | 290 | -70,6 | |||
|
EPS AUD | Released Forecast Spread | -0,24 -0,09 -172.73% | -2,32 -0,14 -1511.11% | -0,33 -0,23 -43.1% | -0,62 -0,18 -248.31% | -2,58 -0,24 -993.22% | 0,18 | -0,88 | ||||
| Announcement Date | 20/02/20 | 20/08/20 | 23/02/21 | 26/08/21 | 24/02/22 | 25/08/22 | 27/02/23 | 30/08/23 | 25/02/24 | - | - |
More events
Past sector events for Mayne Pharma Group Limited
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MYX Stock
- Calendar Mayne Pharma Group Limited
